Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 4
Submit an article Journal homepage
140
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Mitochondrial biogenesis gene POLG correlates with outcome in pediatric acute myeloid leukemia

Shilpi Chaudharya Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, IndiaView further author information
,
Shuvadeep Gangulya Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, IndiaORCID Iconhttps://orcid.org/0000-0002-7296-6088View further author information
ORCID Icon,
Archna Singhb Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, IndiaView further author information
,
Jayanth Kumar Palanichamyb Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, IndiaORCID Iconhttps://orcid.org/0000-0002-3903-7252View further author information
ORCID Icon,
Radhika Bakhshic Shaheed Rajguru College of Applied Sciences for Women, University of Delhi, Delhi, IndiaView further author information
,
Anita Choprad Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, IndiaView further author information
&
Sameer Bakhshia Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, IndiaCorrespondence[email protected]
View further author information
 show all
Pages 1005-1008 | Received 23 Apr 2021, Accepted 16 Nov 2021, Published online: 25 Jan 2022

References

  • Mi J, Tian G, Liu S, et al. The relationship between altered mitochondrial DNA copy number and cancer risk: a meta-analysis. Sci Rep. 2015;5:10039.
  • Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12(10):685–698.
  • Tyagi A, Pramanik R, Vishnubhatla S, et al. Prognostic impact of mitochondrial DNA D-loop variations in pediatric acute myeloid leukemia. Oncotarget. 2019;10(13):1334–1343.
  • Gureev AP, Shaforostova EA, Popov VN. Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1α signaling pathways. Front Genet. 2019;10:435.
  • Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. Cell Press. 2016;166(3):555–566.
  • Chaudhary S, Ganguly S, Palanichamy JK, et al. PGC1A driven enhanced mitochondrial DNA copy number predicts outcome in pediatric acute myeloid leukemia. Mitochondrion. 2021;58:246–254.
  • Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. American Society of Hematology. 2017;129(4):424–447.
  • Tyagi A, Pramanik R, Bakhshi R, et al. Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia. Int J Hematol. 2019;110(2):205–212.
  • Singh B, Owens KM, Bajpai P, et al. Mitochondrial DNA polymerase POLG1 disease mutations and germline variants promote tumorigenic properties. Bai Y, editor. PLoS One. 2015;10(10):e0139846.
  • Wu S, Fahmy N, Alachkar H. The mitochondrial transcription machinery genes are upregulated in acute myeloid leukemia and associated with poor clinical outcome. Metab Open. 2019;2:100009.
  • Pramanik R, Tyagi A, Chopra A, et al. Myeloid sarcoma predicts superior outcome in pediatric AML; can cytogenetics solve the puzzle? Clin Lymphoma, Myeloma Leuk. 2018;18(6):e249–e254.
  • Araujo LF, Siena ADD, Plaça JR, et al. Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma. Sci Rep. 2018;8(1):14190.
  • Long X, Wang X, Chen Y, et al. Association de polymorphismes du gène PolG avec le contenu en ADN mitochondrial et le pronostic de patients CHC. Bull Cancer. 2017;104(6):500–507.
  • Lv M, Zhang S, Dong Y, et al. Polg inhibits gastric cancer glycolysis and viability by suppressing pkm2 phosphorylation. Cancer Manag Res. 2021;13:1559–1570.
  • Yehudai D, Liyanage SU, Hurren R, et al. The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia. Haematologica. 2019;104(5):963–972.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.